ASH 2017 Day 1: Synergistic impact of antigen and rimiducid-dependent stimulatory signals on promoting polyfunctional GoCAR-T cells targeting prostate stem cell antigen (PSCA)

On Day 1 of the ASH 2018 Annual Meeting, IsoPlexis presented “Single-cell multiplex proteomics reveals synergistic impact of antigen and rimiducid-dependent stimulatory signals on promoting polyfunctional GoCAR-T cells targeting prostate stem cell antigen (PSCA)”. The presentation highlighted how IsoCode Chip, IsoPlexis’ core technology developed to detect cellular responses at the single-cell level, was used to assess functional response to prostate stem cell antigen (PSCA) with Bellicum’s proprietary GoCAR-T products targeting PSCA-expressing solid tumors. The single-cell polyfunctional metrics may provide insights into quality check of pre-infusion CAR-T cell products and potential biomarker discovery to predict efficacy, persistence and safety of CAR-T cell therapy in solid tumor. ASH is a leading conference in hematology where clinicians and researchers deliver the latest breakthroughs across blood-related diseases.

Share This Article
Be in the Know.
Unlock Resources

We will always keep your personal information safe. Complete this form to get unlimited access to all of our web resources and join over 10,000 leading researchers who receive industry pioneers' backed data straight to their inbox. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy.

You may unsubscribe and update your email subscription at any time.